Literature DB >> 26884056

Cellular Uptake and Intra-Organ Biodistribution of Functionalized Silica-Coated Gold Nanorods.

Bin Gao1, Jun Xu2, Ke-Wu He2, Lei Shen2, Hao Chen2, Hui-Jun Yang2, Ai-Hua Li2, Wei-Hua Xiao3.   

Abstract

PURPOSE: To develop a new nanobiosystem based on folate-functionalized silica-coated gold nanorods and to investigate its cellular uptake and intra-organ biodistribution in vitro and in vivo. PROCEDURES: Ellipsoidal silica-coated gold nanorods (GNRs@SIO2) were prepared by seeded growth method using silicon dioxide (SIO2) as the shell material. Rhodamine-labeled GNRs@SiO2-folic acid (FA) were obtained by reacting the amino group located on GNRs@SiO2-FA with rhodamine isothiocyanate. The characteristics of the prepared GNRs@SiO2-FA were studied using transmission electron microscopy (TEM) and UV spectra. The 3-[4, 5-dimethylthiazol-2-yl]-2,5 diphenyltetrazolium bromide (MTT) colorimetric method was used to assess the biocompatibility of GNRs@SiO2-FA, and their uptake into cells was observed using TEM. In vivo experiments of cellular uptake and study of the intra-organ biodistribution of GNRs@SiO2-FA were detected using intrinsic two-photon luminescence.
RESULTS: Analysis of UV spectra confirmed the successfu1 preparation of GNRs@SiO2-FA. Results of the MTT assay demonstrated that surface modification of GNRs@SiO2-FA resulted in excellent biocompatibility. TEM examination revealed that GNRs@SiO2-FA entered the cells via endocytosis, which could connect to cancer cells with high folic acid expression. We found that GNRs exhibit bright luminescence and could be visualized in vivo by direct imaging of these particles within the tissue. Additionally, GNRs@SiO2-FA could specifically bind to tumor cells. GNRs@SiO2-FA entered tumor cells within 24 h and had a heterogeneous distribution with higher accumulation at the tumor cytoplasm.
CONCLUSION: GNRs@SiO2-FA can bind to cells and were found to be internalized by targeted folate receptor-expressing cells via a ligand-receptor-mediated endocytosis pathway, which is very useful in diagnosing diseases as well as in treating neoplasm with I-125 particles.

Entities:  

Keywords:  Folic acid; Gold nanorods; SiO2; Two-photon-induced photoluminescence

Mesh:

Substances:

Year:  2016        PMID: 26884056     DOI: 10.1007/s11307-016-0938-9

Source DB:  PubMed          Journal:  Mol Imaging Biol        ISSN: 1536-1632            Impact factor:   3.488


  40 in total

1.  Enhanced multi-spectral imaging of live breast cancer cells using immunotargeted gold nanoshells and two-photon excitation microscopy.

Authors:  Lissett Bickford; Jiantang Sun; Kun Fu; Nastassja Lewinski; Vengadesan Nammalvar; Joseph Chang; Rebekah Drezek
Journal:  Nanotechnology       Date:  2008-06-24       Impact factor: 3.874

2.  Highly effective photodynamic inactivation of E. coli using gold nanorods/SiO2 core-shell nanostructures with embedded verteporfin.

Authors:  Kostiantyn Turcheniuk; Volodymyr Turcheniuk; Charles-Henri Hage; Tetiana Dumych; Rostyslav Bilyy; Julie Bouckaert; Laurent Héliot; Vladimir Zaitsev; Rabah Boukherroub; Sabine Szunerits
Journal:  Chem Commun (Camb)       Date:  2015-11-25       Impact factor: 6.222

3.  Biocompatible triplex Ag@SiO2@mTiO2 core-shell nanoparticles for simultaneous fluorescence-SERS bimodal imaging and drug delivery.

Authors:  Yunqing Wang; Lingxin Chen; Ping Liu
Journal:  Chemistry       Date:  2012-03-29       Impact factor: 5.236

Review 4.  Gold nanoparticles for biology and medicine.

Authors:  David A Giljohann; Dwight S Seferos; Weston L Daniel; Matthew D Massich; Pinal C Patel; Chad A Mirkin
Journal:  Angew Chem Int Ed Engl       Date:  2010-04-26       Impact factor: 15.336

5.  In vivo photoacoustic therapy with cancer-targeted indocyanine green-containing nanoparticles.

Authors:  Junping Zhong; Sihua Yang; Xiaohui Zheng; Ting Zhou; Da Xing
Journal:  Nanomedicine (Lond)       Date:  2012-09-10       Impact factor: 5.307

6.  Visualizing systemic clearance and cellular level biodistribution of gold nanorods by intrinsic two-photon luminescence.

Authors:  Ling Tong; Wei He; Yanshu Zhang; Wei Zheng; Ji-Xin Cheng
Journal:  Langmuir       Date:  2009-11-03       Impact factor: 3.882

7.  Noble metal nanoparticles applications in cancer.

Authors:  João Conde; Gonçalo Doria; Pedro Baptista
Journal:  J Drug Deliv       Date:  2011-10-05

8.  A Light-Driven Therapy of Pancreatic Adenocarcinoma Using Gold Nanorods-Based Nanocarriers for Co-Delivery of Doxorubicin and siRNA.

Authors:  Feng Yin; Chengbin Yang; Qianqian Wang; Shuwen Zeng; Rui Hu; Guimiao Lin; Jinglin Tian; Siyi Hu; Rong Feng Lan; Ho Sup Yoon; Fei Lu; Kuan Wang; Ken-Tye Yong
Journal:  Theranostics       Date:  2015-04-20       Impact factor: 11.556

9.  Gold nanorods/mesoporous silica-based nanocomposite as theranostic agents for targeting near-infrared imaging and photothermal therapy induced with laser.

Authors:  Yang Liu; Ming Xu; Qing Chen; Guannan Guan; Wen Hu; Xiuli Zhao; Mingxi Qiao; Haiyang Hu; Ying Liang; Heyun Zhu; Dawei Chen
Journal:  Int J Nanomedicine       Date:  2015-07-28

10.  The most effective gold nanorod size for plasmonic photothermal therapy: theory and in vitro experiments.

Authors:  Megan A Mackey; Moustafa R K Ali; Lauren A Austin; Rachel D Near; Mostafa A El-Sayed
Journal:  J Phys Chem B       Date:  2014-01-23       Impact factor: 2.991

View more
  3 in total

Review 1.  The Toxicity Of Metallic Nanoparticles On Liver: The Subcellular Damages, Mechanisms, And Outcomes.

Authors:  Ying Yao; Yiteng Zang; Jing Qu; Meng Tang; Ting Zhang
Journal:  Int J Nanomedicine       Date:  2019-11-07

Review 2.  Improvement of Gold Nanorods in Photothermal Therapy: Recent Progress and Perspective.

Authors:  Shengnan Liao; Wang Yue; Shuning Cai; Quan Tang; Weitong Lu; Lingxiao Huang; Tingting Qi; Jinfeng Liao
Journal:  Front Pharmacol       Date:  2021-04-22       Impact factor: 5.810

Review 3.  Surface modification of plasmonic noble metal-metal oxide core-shell nanoparticles.

Authors:  Somayeh Talebzadeh; Clémence Queffélec; D Andrew Knight
Journal:  Nanoscale Adv       Date:  2019-10-30
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.